Stansberry Asset Management’s Strata Critical Medical Inc SRTA Stock Holding History

Stansberry Asset Management’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-103,921	Closed	-$372K	–	101
2022 Q4	$372K	Buy	103,921 +2,391	+2%	+$10.2K	0.08%	93
2022 Q3	$410K	Sell	101,530 -2,334	-2%	-$12K	0.09%	90
2022 Q2	$463K	Sell	103,864 -70,659	-40%	-$510K	0.1%	93
2022 Q1	$1.48M	Buy	174,523 +12,058	+7%	+$84.7K	0.24%	62
2021 Q4	$1.44M	Buy	+162,465	New	+$1.54M	0.23%	55

Other funds holding SRTA

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

HVCM

HG Vora Capital Management New York $197M AUM 17.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BGIM

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

Stansberry Asset Management's SRTA Position: Q1 2023 in Review

Stansberry Asset Management sold out of Strata Critical Medical Inc (SRTA) in Q1 2023, closing a stake of 103,921 shares — an estimated $372K sold.

Stansberry Asset Management first reported a position in SRTA in Q4 2021 and held it in 5 quarters. The position peaked at $1.48M in Q1 2022. 93 funds tracked by Wall St. Rank hold SRTA as of Q1 2023.

Stansberry Asset Management reported no remaining Strata Critical Medical Inc position as of Q1 2023 after selling out during the quarter.
Stansberry Asset Management sold 103,921 Strata Critical Medical Inc shares in Q1 2023, an estimated $372K.
Stansberry Asset Management first reported a position in Strata Critical Medical Inc in Q4 2021 and held it in 5 quarters.
Stansberry Asset Management's Strata Critical Medical Inc position peaked at $1.48M in Q1 2022.
93 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2023.

Based on Stansberry Asset Management's 13F filing for Q1 2023, filed 12 May 2023.